Redcare Pharmacy NV (LON:0RJT)
London · Delayed Price · Currency is GBP · Price in EUR 65.45
+0.95 (1.47%)
At close: Dec 23, 2025
Redcare Pharmacy NV Revenue
Redcare Pharmacy NV had revenue of 719.23M EUR in the quarter ending September 30, 2025, with 25.18% growth. This brings the company's revenue in the last twelve months to 2.82B, up 26.68% year-over-year. In the year 2024, Redcare Pharmacy NV had annual revenue of 2.37B with 31.79% growth.
Revenue (ttm)
2.82B EUR
Revenue Growth
+26.68%
P/S Ratio
0.47
Revenue / Employee
1.54M EUR
Employees
1,827
Market Cap
1.15B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.37B | 571.82M | 31.79% |
| Dec 31, 2023 | 1.80B | 594.41M | 49.35% |
| Dec 31, 2022 | 1.20B | 144.03M | 13.58% |
| Dec 31, 2021 | 1.06B | 92.26M | 9.53% |
| Dec 31, 2020 | 968.06M | 267.05M | 38.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |